​

Oncology Institute (TOI) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Oncology Institute Revenue Highlights

Latest Revenue (Y)

$393.41M

Latest Revenue (Q)

$99.90M

Main Segment (Y)

Health Care, Patient Service

Oncology Institute Revenue by Period

Oncology Institute Revenue by Year

DateRevenueChange
2024-12-31$393.41M21.33%
2023-12-31$324.24M28.42%
2022-12-31$252.48M24.37%
2021-12-31$203.00M8.26%
2020-12-31$187.51M20.66%
2019-12-31$155.41M37.33%
2018-12-31$113.16M-

Oncology Institute generated $393.41M in revenue during NA 2024, up 21.33% compared to the previous quarter, and up 253.15% compared to the same period a year ago.

Oncology Institute Revenue by Quarter

DateRevenueChange
2024-09-30$99.90M1.34%
2024-06-30$98.58M4.13%
2024-03-31$94.67M10.35%
2023-12-31$85.79M4.57%
2023-09-30$82.03M2.26%
2023-06-30$80.22M5.29%
2023-03-31$76.19M6.68%
2022-12-31$71.42M9.92%
2022-09-30$64.98M6.66%
2022-06-30$60.92M10.44%
2022-03-31$55.16M5.46%
2021-12-31$52.30M0.06%
2021-09-30$52.27M4.88%
2021-06-30$49.84M2.60%
2021-03-31$48.58M-74.09%
2020-12-31$187.51M296.86%
2020-09-30$47.25M-0.06%
2020-06-30$47.28M7.40%
2020-03-31$44.02M17.83%
2018-12-31$37.36M-

Oncology Institute generated $99.90M in revenue during Q3 2024, up 1.34% compared to the previous quarter, and up 124.53% compared to the same period a year ago.

Oncology Institute Revenue Breakdown

Oncology Institute Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Fee For Service$136.20M$143.13M$105.44M$69.79M
Health Care, Patient Service$204.88M$213.50M$166.78M$124.07M
Capitated Revenue$68.69M$70.37M$61.34M$54.28M
Clinical Research Trials And Other Revenue$8.61M$6.90M$6.36M$6.38M
Dispensary Revenue$179.92M$103.83M$79.34M$72.55M

Oncology Institute's latest annual revenue breakdown by segment (product or service), as of Dec 24: Health Care, Patient Service (34.24%), Dispensary Revenue (30.07%), Fee For Service (22.76%), Capitated Revenue (11.48%), and Clinical Research Trials And Other Revenue (1.44%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Clinical Research Trials And Other Revenue$4.14M$1.94M$2.53M$3.62M$1.60M$1.68M$1.82M$1.51M$1.59M$1.43M
Capitated Revenue$36.21M$14.81M$17.67M$37.02M$16.79M$16.57M$16.53M$16.36M$13.94M$14.52M
Health Care, Patient Service$102.68M$49.75M$52.45M$109.81M$53.43M$50.27M$47.99M$44.63M$39.11M$35.06M
Fee For Service$66.47M$34.94M$34.79M$72.79M$36.64M$33.70M$31.47M$28.27M$25.16M$20.54M
Dispensary Revenue$92.03M$48.21M$39.68M$54.40M$25.20M$24.24M$21.61M$18.84M$20.22M$18.68M

Oncology Institute's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Health Care, Patient Service (34.05%), Dispensary Revenue (30.52%), Fee For Service (22.05%), Capitated Revenue (12.01%), and Clinical Research Trials And Other Revenue (1.37%).

Oncology Institute Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JYNTJoint$51.90T$30.20M
UHSUniversal Health Services$15.83B$3.96B
AGLagilon health$6.06B$1.45B
EHCEncompass Health$5.37B$1.35B
SEMSelect Medical$5.19B$1.76B
ENSGEnsign Group$4.26B$1.08B
BKDBrookdale Senior Living$3.13B$784.17M
SGRYSurgery Partners$3.11B$770.40M
MDPediatrix Medical Group$2.01B$511.16M
LFSTLifeStance Health Group$1.25B$312.72M
ADUSAddus HomeCare$1.15B$289.79M
PNTGPennant Group$695.24M$168.75M
CCMConcord Medical Services$537.40M$34.94M
TOIOncology Institute$393.41M$99.90M
SNDASonida Senior Living$304.33M$74.75M

TOI Revenue FAQ

What is Oncology Institute’s yearly revenue?

Oncology Institute's yearly revenue for 2024 was $393.41M, representing an increase of 21.33% compared to 2023. The company's yearly revenue for 2023 was $324.24M, representing an increase of 28.42% compared to 2022. TOI's yearly revenue for 2022 was $252.48M, representing an increase of 24.37% compared to 2021.

What is Oncology Institute’s quarterly revenue?

Oncology Institute's quarterly revenue for Q3 2024 was $99.9M, a 1.34% increase from the previous quarter (Q2 2024), and a 21.78% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $98.58M, a 4.13% increase from the previous quarter (Q1 2024), and a 22.88% increase year-over-year (Q2 2023). TOI's quarterly revenue for Q1 2024 was $94.67M, a 10.35% increase from the previous quarter (Q4 2023), and a 24.25% increase year-over-year (Q1 2023).

What is Oncology Institute’s revenue growth rate?

Oncology Institute's revenue growth rate for the last 3 years (2022-2024) was 55.82%, and for the last 5 years (2020-2024) was 109.80%.

What are Oncology Institute’s revenue streams?

Oncology Institute's revenue streams in c 24 are Fee For Service, Health Care, Patient Service, Capitated Revenue, Clinical Research Trials And Other Revenue, and Dispensary Revenue. Fee For Service generated $136.2M in revenue, accounting 22.76% of the company's total revenue, down -4.85% year-over-year. Health Care, Patient Service generated $204.88M in revenue, accounting 34.24% of the company's total revenue, down -4.04% year-over-year. Capitated Revenue generated $68.69M in revenue, accounting 11.48% of the company's total revenue, down -2.39% year-over-year. Clinical Research Trials And Other Revenue generated $8.61M in revenue, accounting 1.44% of the company's total revenue, up 24.83% year-over-year. Dispensary Revenue generated $179.92M in revenue, accounting 30.07% of the company's total revenue, up 73.27% year-over-year.

What is Oncology Institute’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Oncology Institute was Health Care, Patient Service. This segment made a revenue of $204.88M, representing 34.24% of the company's total revenue.